COMBOGESIC

ACETAMINOPHEN AND IBUPROFEN · Hikma Pharmaceuticals USA Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for COMBOGESIC, covering 2023-03-01 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain [Phase 3]